Literature DB >> 9630500

Evaluation of auramine genotoxicity in primary rat and human hepatocytes and in the intact rat.

A Martelli1, G B Campart, R Canonero, R Carrozzino, F Mattioli, L Robbiano, M Cavanna.   

Abstract

Auramine, a dye previously found to be a liver carcinogen in both mice and rats, was evaluated for its DNA-damaging and clastogenic activities in primary cultures of rats and human hepatocytes and for the induction of DNA single-strand breaks in the liver and urinary bladder mucosa of intact rats. A similar dose-dependent frequency of DNA fragmentation was revealed by the alkaline elution technique in metabolically competent primary cultures of both rat and human hepatocytes exposed for 20 h to subtoxic concentrations ranging from 10 to 32 microM. In contrast, neither rat nor human hepatocytes displayed an increased frequency of micronuclei after a 48-h exposure to the same auramine concentrations. In rats given a single oral dose of 125, 250 or 500 mg kg-1 auramine, the Comet assay revealed a significant increase in the frequency of DNA lesions in the liver and in the urinary bladder mucosa, the effect being slightly more marked in the liver. Taken as a whole and compared with previous findings, these results suggest that auramine is biotransformed into reactive species in target organs of both rats and humans, and that this dye might play by itself the main role in the increased incidence of bladder cancer which has been judged as causally related to its manufacture. Copyright 1998 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9630500     DOI: 10.1016/s1383-5718(98)00037-0

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  1 in total

1.  Auramine O, an incense smoke ingredient, promotes lung cancer malignancy.

Authors:  Jia-Chen Tung; Wei-Chien Huang; Juan-Cheng Yang; Guan-Yu Chen; Chi-Chen Fan; Yu-Chuan Chien; Pei-Shan Lin; Shih-Chun Candice Lung; Wei-Chao Chang
Journal:  Environ Toxicol       Date:  2017-07-19       Impact factor: 4.119

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.